Patents by Inventor Philippe Benaroch

Philippe Benaroch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MYELOID CELLS MODIFIED BY CHIMERIC ANTIGEN RECEPTOR WITH CD40 AND USES THEREOF FOR ANTI-CANCER THERAPY
    Publication number: 20250222106
    Abstract: A modified myeloid cell comprises a chimeric antigen receptor (CAR), or a modified induced pluripotent stem cell (iPS) or hematopoietic stem cell (HSC) comprising a CAR, wherein said CAR comprises an extracellular antigen-binding domain which binds to a tumor antigen or a tumor microenvironment (TME) antigen; a transmembrane domain; and an intracellular signaling domain comprising the CD40 cytotail. Therapeutic uses of the modified myeloid cell are disclosed.
    Type: Application
    Filed: April 7, 2023
    Publication date: July 10, 2025
    Inventors: Philippe BENAROCH, Jovan NIKOLIC
  • CLUSTER OF DIFFERENTIATION 36 (CD36) AS A THERAPEUTIC TARGET FOR HIV INFECTION
    Publication number: 20150259429
    Abstract: The present invention concerns new methods for treating HIV infection by using CD36 inhibitors, antibodies or conjugates, and methods for identifying new molecules of interest for treating HIV infection.
    Type: Application
    Filed: August 27, 2013
    Publication date: September 17, 2015
    Inventors: Philippe Benaroch, Stefano Berre